Chauche Thierry, CFO of Sagimet Biosciences Inc. ($SGMT), sold shares once on the open market in the last year, totaling about $7,000. His most recent sale occurred on February 10, 2026. These sales rank 11,345th among 11,678 insiders, far below the average of 8.6 million per seller and 6.4 transactions. He made no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 19, 2026 | Sagimet Biosciences Inc. | $SGMT | Chauche Thierry | Chief Financial Officer | A | Series A Common Stock | 44000 | $0.00 | 59,688.0000 | 32,464,893 | 280.47% | 0.14% |
| Feb. 19, 2026 | Sagimet Biosciences Inc. | $SGMT | Chauche Thierry | Chief Financial Officer | A | Stock Option (Right to Buy) | 88000 | $0.00 | 88,000.0000 | 32,464,893 | 9999.99% | 0.27% |
| Feb. 10, 2026 | Sagimet Biosciences Inc. | $SGMT | Chauche Thierry | Chief Financial Officer | S | Series A Common Stock | 1312 | $5.36 | 15,688.0000 | 32,464,893 | 7.72% | 0.00% |
| Feb. 6, 2025 | Sagimet Biosciences Inc. | $SGMT | Chauche Thierry | Chief Financial Officer | A | Series A Common Stock | 17000 | $0.00 | 17,000.0000 | 31,350,725 | 9999.99% | 0.05% |
| Feb. 6, 2025 | Sagimet Biosciences Inc. | $SGMT | Chauche Thierry | Chief Financial Officer | A | Stock Option (Right to Buy) | 69000 | $0.00 | 69,000.0000 | 31,350,725 | 9999.99% | 0.22% |
| May 6, 2024 | Sagimet Biosciences Inc. | $SGMT | Chauche Thierry | Chief Financial Officer | A | Stock Option (Right to Buy) | 587181 | $0.00 | 587,181.0000 | 29,039,427 | 9999.99% | 2.02% |